Central venous line thrombosis in children and young adults with thalassemia major

Pediatric Hematology and Oncology

Volumn 21, Issue 5, 2004, Pages 375-381

  Finkelstein, Yaron ^a   Yaniv, Isaac ^a   Berant, Michael ^a   Zilber, Rama ^a   Garty, Ben Zion ^a   Epstein, Orit ^b,c   Lahav, Judith ^b,c   Tamary, Hannah ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Central venous line; Children; Thalassemia; Thrombophilia

Indexed keywords

DEFEROXAMINE;

ADOLESCENT; ADULT; ARTICLE; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; HUMAN; IRON CHELATION; MONITORING; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; SYMPTOMATOLOGY; THALASSEMIA MAJOR; THROMBOCYTE COUNT; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; VENOUS THROMBOSIS;

EID: 3042728857     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010490457042     Document Type: Article

References (28)

1. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwellng intravenous catheters in high-risk beta-thalassemia. Blood. 2000;95:1229-1236.
2. Miskin H, Yaniv I, Berant M, Hershko C, Tamary H. Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation. Eur J Haematol. 2003;70:398-403.
3. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboemobolic Complications. J Pediatr. 1998;133:770-776.
4. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr Opin Hematol. 2003;10:369-374.
5. McKinley S, Mackenzie A, Finfer S, Ward R. Penfold J. Incidence and predictors of central venous catheter related infection in intensive care patients. Anaesth Intensive Care. 1999;27:164-169.
6. Nowak-Göttl U, Dübbers A, Kececioglu D, et al. Factor V Leiden, protein C, and lipoprotein(a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr. 1997;131:608-612.
7. Eldor A, Durst R, Hy-Am E, et al. The chronic hypercoagulable state in patients with β-thalassemia major is already present in childhood. Br J Haematol. 1999;107:739-746.
8. Borgna Pignatti C, Carnellim V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99:76-79.
9. Logothetis J, Constantoulakis M, Economidou J. Thalassemia major (homozygous beta-thalassemia): a survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology. 1972;22:294-304.
10. Borgna-Pignatti C, Rugolotto S, DeStefano P, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227-231.
11. Moratelli S, DeSanctis V, Gemmati D, et al. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab. 1998;11:915-921.
12. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz EA. Thromboembolic complications inthalassemia major. Acta Haematol. 1992;87:71-74.
13. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99:36-43.
14. vonDepka M, Nowak-Gottl U, Eisert R, et al. Increased lipoprotein (A) levels as an independent risk factor for venous thromboembolism. Blood. 2000;96:3364-68.
15. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80:1998-2005.
16. Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134:532-537.
17. Borenstain-BenYashar V, Barnholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol. 1993;44:63-65.
18. Kuypers FA, Yuan J, Lewis RA. Membrane phospholipid asymmetry in human thalassemia. Blood. 1998;91:3044-3048.
19. Ruf A, Pick M, Deutsch V, et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassemia major. Br J Haematol. 1997;98:51-56.
20. Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia. Thromb Haemostat. 1996;76:322-327.
21. Musumeci S, Leonardi S, Di Dio R, Fischer A, Di Costa G. Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematol. 1987;77:30-33.
22. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000;111:467-473.
23. Beck C, Dubois J, Grignon A, Lacroix J, David M. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. J Pediatr. 1998;133:237-241.
24. Glaser DW, Medeitos D, Rollins N, Buchanan GR. Catheter-related thrombosis in children with cancer. J Pediatr. 2001;138:255-259.
25. David M, Manco-Johnson M, Andrew M. Diagnosis and treatment of venous thromboembolism in children and adolescents. Thromb Haemost. 1995;74:791-792.
26. Nowak-Gottl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost. 2001;86:464-474.
27. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-1230.
28. Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L. PARKAA Investigators. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood. 2003;101:4273-4278.